* A local business lobby, Cámara Nacional de la Industria de Transformación (Canacintra), has come out against the measures announced on 13 March by Mexico’s federal finance ministry (SHCP) to guarantee the supply of medicines. With more information to be unveiled on 20 March, the SHCP had revealed that this would be done through a direct adjudication process between 16 April and 30 June and international tendering. In a statement, however, Canacintra challenges the SHCP’s claim that these mechanisms seek to reduce the possibility of irregularities which affect the supply of medicines, arguing instead that a direct adjudication process would be less transparent.
End of preview - This article contains approximately 102 words.
Subscribers: Log in now to read the full article
Not a Subscriber?
Choose from one of the following options